Drugs / adjuvanted
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Refused (EMA) | EU (EMA) | Focetria | — | 2007-05-07 | europa.eu ↗ |
| Approved | EU (EMA) | Hexavac | — | 2000-10-23 | europa.eu ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06676644 | Nov 2024 → Dec 2027 expected | — | National Taiwan University Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adjuvanted | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06676644 ↗ |
| Known as | aIIV4 | “adjuvanted (aIIV4) influenza vaccine in the Taiwanses elderly with chronic medical conditions” NCT06676644 ↗ |
| Modality | Vaccine | “adjuvanted (aIIV4) influenza vaccine” NCT06676644 ↗ |